www.fool.com/investing/2025/04/23/why...
#SMMT #BGNE #AKES.F […]
[Original post on fool.com]
#BGNE TEVIMBRA Approved in U.S. for First-line Treatment of Gastric and Gastroesophageal Junction Cancers in Combination with Chemotherapy
www.stocktitan.net/news/BGNE/tevimbra-appro...
#BGNE BeiGene to Change Nasdaq Ticker Symbol to “ONC” on January 2; Present at 43rd Annual J.P. Morgan Healthcare Conference
www.stocktitan.net/news/BGNE/bei-gene-to-ch...
#BGNE BeiGene Announces Global Licensing Agreement for MAT2A Inhibitor
www.stocktitan.net/news/BGNE/bei-gene-annou...
Breaking News: ( NASDAQ: #BGNE ) European Commission Approves BeiGene's TEVIMBRA for First-Line Treatment of Advanced/Metastatic Esophageal Squamous Cell Carcinoma and Gastric or Gastroesophageal Junction Cancer
#StockMarket #News
#BGNE BeiGene to Present at Upcoming Investor Conferences
www.stocktitan.net/news/BGNE/bei-gene-to-pr...
#LH #BGNE Labcorp CFO Glenn Eisenberg Announces Plans to Retire
www.stocktitan.net/news/LH/labcorp-cfo-glen...
News; ( NASDAQ: #BGNE ) BeiGene Announces Settlement of Litigation Against Generic Filer of BRUKINSA
#StockMarket #News
#BGNE BeiGene Announces Settlement of Litigation Against Generic Filer of BRUKINSA
www.stocktitan.net/news/BGNE/bei-gene-annou...
Breaking News: ( NASDAQ: #BGNE ) BeiGene Ltd. (NASDAQ: BGNE) Records 52-Week High Monday Morning
#StockMarket #News
NEWS: ( NASDAQ: #BGNE ) Global Oncology Innovator BeiGene Appoints Shalini Sharp to Board of Directors
#StockMarket #News
Breaking News: ( NASDAQ: #BGNE ) Investors Watch Key Players in Oncology as Cancer Cases Set to Skyrocket
#StockMarket #News
News; ( NASDAQ: #BGNE ) BeiGene Ltd. (NASDAQ: BGNE) Records 52-Week High Wednesday Morning
#StockMarket #News
Breaking News: ( NASDAQ: #BGNE ) BeiGene's BGB-16673 Receives U.S. FDA Fast Track Designation for CLL/SLL
#StockMarket #News